Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program

BACKGROUND: Data on the epidemiology and treatment of atrial fibrillation in the Africa/Middle East region are limited, and the use of novel oral anticoagulants and their effectiveness in real-world clinical practice has not been evaluated. METHODS AND RESULTS: This study used prospectively collecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Azar, Rabih R., Ragy, Hany I., Kozan, Omer, El Khuri, Maurice, Bazergani, Nooshin, Marler, Sabrina, Teutsch, Christine, Ibrahim, Mohamed, Lip, Gregory Y.H., Huisman, Menno V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065192/
https://www.ncbi.nlm.nih.gov/pubmed/33912651
http://dx.doi.org/10.1016/j.ijcha.2021.100763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065192/
https://www.ncbi.nlm.nih.gov/pubmed/33912651
http://dx.doi.org/10.1016/j.ijcha.2021.100763

Ejemplares similares